Leqvio 284 MG/1.5 ML syringe 1.5ML
Ended Awarded
- Contract number
- SPE2DB26FNNYT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,256
Award facts
- Contract value 100% obligated
- $23,255.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,255.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Leqvio 284 mg/1.5 ml syringes, with an ultimate completion date of December 3, 2025. This non-set-aside contract represents a competitive award for pharmaceutical procurement supporting federal medical supply needs. The delivery order is classified as a child contract, indicating it derives from a larger vehicle agreement—specifically AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This award reflects AmerisourceBergen's critical role as a major pharmaceutical distributor serving the Defense Health Agency and broader military healthcare systems. Leqvio is a prescription medication for cardiovascular health management, demonstrating the company's ongoing responsibility for delivering specialty medications essential to federal medical procurement. As the prime vendor under the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen maintains the flexibility to fulfill diverse pharmaceutical requirements across multiple therapeutic domains for military and veteran healthcare operations worldwide. The firm fixed-price structure and competitive award process underscore the company's demonstrated capability to meet federal procurement standards and deliver medical commodities efficiently.
Quick answers
Who was awarded contract SPE2DB26FNNYT?
SPE2DB26FNNYT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FNNYT worth?
The government has obligated $23,256 on SPE2DB26FNNYT.
Is contract SPE2DB26FNNYT an order under another contract?
Yes. SPE2DB26FNNYT is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB26FNNYT competed?
The extent of competition for SPE2DB26FNNYT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award